Effects of disopyramide on left ventricular diastolic function in hypertrophic cardiomyopathy.

PubWeight™: 1.38‹?› | Rank: Top 10%

🔗 View Article (PMID 8059710)

Published in Am J Cardiol on August 15, 1994

Authors

M A Fifer1, P T O'Gara, B A McGovern, M J Semigran

Author Affiliations

1: Department of Medicine, Massachusetts General Hospital, Boston.

Articles citing this

Hypertrophic Cardiomyopathy. Curr Treat Options Cardiovasc Med (1999) 0.76

Effects of disopyramide on diastolic function in hypertrophic cardiomyopathy. Am J Cardiol (1995) 0.75

Articles by these authors

Apoptosis in myocytes in end-stage heart failure. N Engl J Med (1996) 6.19

The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest (1996) 5.29

Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). Circulation (1998) 2.97

Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation (1995) 2.97

Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol (1995) 2.84

Apoptosis in heart failure: release of cytochrome c from mitochondria and activation of caspase-3 in human cardiomyopathy. Proc Natl Acad Sci U S A (1999) 2.42

Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation (1993) 2.20

Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci U S A (1998) 2.19

A clinical rule to predict preserved left ventricular ejection fraction in patients after myocardial infarction. Ann Intern Med (1994) 2.17

ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). J Heart Valve Dis (1998) 1.83

Sex differences in cardiac arrest survivors. Circulation (1996) 1.57

Effect of vesnarinone on cardiac function in patients with severe congestive heart failure. Am Heart J (1998) 1.52

Inhaled nitric oxide improves exercise capacity in patients with severe heart failure and right ventricular dysfunction. Am J Cardiol (1998) 1.47

Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis. J Am Coll Cardiol (1989) 1.44

Inspiratory muscle training in patients with chronic heart failure awaiting cardiac transplantation: results of a pilot clinical trial. Phys Ther (1997) 1.43

Acute aortic dissection and its variants. Toward a common diagnostic and therapeutic approach. Circulation (1995) 1.30

Klippel-Trénaunay syndrome with multiple pulmonary emboli--an unusual cause of progressive pulmonary dysfunction. J Vasc Surg (1995) 1.25

Implantation of transvenous nonthoracotomy cardioverter-defibrillator systems in patients with permanent endocardial pacemakers. Am Heart J (1995) 1.22

Treatment of ventricular tachycardia by transcatheter radiofrequency ablation in patients with ischemic heart disease. Circulation (1994) 1.09

Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. Am J Cardiol (2001) 1.08

Asystole after exercise in healthy persons. Ann Intern Med (1994) 1.07

Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation (1991) 1.06

Electrophysiologic response to moricizine in patients with sustained ventricular arrhythmias. Ann Intern Med (1992) 1.05

Adenosine and the treatment of supraventricular tachycardia. Am J Med (1992) 1.03

Cardiovascular complications following liver transplantation. Clin Transplant (1995) 1.01

Usefulness of echocardiographic determined tricuspid regurgitation in predicting event-free survival in severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic cardiomyopathy. Am J Cardiol (1998) 1.00

Analysis of the initiation of spontaneous monomorphic ventricular tachycardia by stored intracardiac electrograms. J Am Coll Cardiol (1994) 1.00

Comparison of the effects of nitric oxide, nitroprusside, and nifedipine on hemodynamics and right ventricular contractility in patients with chronic pulmonary hypertension. Chest (2001) 0.98

Transvenous cardioverter-defibrillator implantation via persistent left superior vena cava. Am Heart J (1995) 0.98

Geriatric patients with acute myocardial infarction: Cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis. Am Heart J (1996) 0.94

Oxygen therapy improves cardiac index and pulmonary vascular resistance in patients with pulmonary hypertension. Chest (2001) 0.93

Inhaled nitric oxide increases coronary artery patency after thrombolysis. Circulation (1996) 0.93

Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy. J Am Coll Cardiol (1998) 0.92

Outcomes in recipients of combined heart-kidney transplantation: multiorgan, same-donor transplant study of the International Society of Heart and Lung Transplantation/United Network for Organ Sharing Scientific Registry. Transplantation (1997) 0.89

Complications after overdose with tricyclic antidepressants. Crit Care Med (1985) 0.89

Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. J Heart Lung Transplant (2000) 0.88

Biopsy-induced flail tricuspid leaflet and tricuspid regurgitation following orthotopic cardiac transplantation. Am J Cardiol (1996) 0.88

Operation for recurrent ventricular tachycardia. Predictors of short- and long-term efficacy. J Thorac Cardiovasc Surg (1994) 0.87

Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation (1989) 0.87

Low energy conversion of atrial fibrillation in the sheep. J Am Coll Cardiol (1992) 0.87

Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope. Am J Cardiol (1993) 0.86

Care of acute myocardial infarction by noninvasive and invasive cardiologists: procedure use, cost and outcome. J Am Coll Cardiol (1996) 0.86

Linearity of the left ventricular end-systolic pressure-volume relation in patients with severe heart failure. J Am Coll Cardiol (1989) 0.86

The prevention and management of iodine-induced hyperthyroidism and its cardiac features. Thyroid (1998) 0.85

Changes in health status and quality of life and the impact of uncertainty in patients who survive life-threatening arrhythmias. Heart Lung (1999) 0.84

Infective endocarditis. Curr Probl Cardiol (2001) 0.84

Mechanism of sustained monomorphic ventricular tachycardia in systemic sclerosis. Am J Cardiol (1999) 0.83

Transient right bundle branch block causing R wave attenuation postdefibrillation. Pacing Clin Electrophysiol (1997) 0.83

Current treatment of patients surviving out-of-hospital cardiac arrest. JAMA (1991) 0.82

Long-term serial changes in left ventricular function and reversal of ventricular dilatation after valve replacement for chronic aortic regurgitation. Circulation (1988) 0.81

Evaluation of ischemic heart disease in potential lung transplant recipients. J Heart Lung Transplant (1995) 0.81

The treatment of patients with infected implantable cardioverter-defibrillator systems. J Thorac Cardiovasc Surg (1997) 0.81

Determinants of successful nonthoracotomy cardioverter-defibrillator implantation: experience in 101 patients using two different lead systems. J Am Coll Cardiol (1993) 0.80

Effect of dextran and aspirin on platelet adherence after transluminal angioplasty of normal canine coronary arteries. Am J Cardiol (1984) 0.80

Efficacy and safety of procainamide in preventing arrhythmias after coronary artery bypass surgery. Am J Cardiol (1996) 0.80

Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts. Am J Cardiol (1989) 0.79

Intramural mechanics in hypertrophic cardiomyopathy: functional mapping with strain-rate MR imaging. Radiology (1995) 0.79

Adverse cardiac effects of combined neuroleptic ingestion and tricyclic antidepressant overdose. J Clin Psychopharmacol (1990) 0.79

Delirium during intra-aortic balloon pump therapy. Incidence and management. Psychosomatics (1992) 0.79

Positive inotropic and lusitropic effects of intravenous flosequinan in patients with heart failure. J Am Coll Cardiol (1992) 0.79

Three-year outcome of a nonthoracotomy approach to cardioverter-defibrillator implantation in 189 consecutive patients. Am J Cardiol (1994) 0.79

Cessation of platelet-mediated cyclic canine coronary occlusion after thrombolysis by combining nitric oxide inhalation with phosphodiesterase-5 inhibition. J Am Coll Cardiol (2001) 0.78

Fatal intracerebral hemorrhage following thrombolytic therapy of embolic myocardial infarction in unsuspected infective endocarditis. Clin Cardiol (1994) 0.78

Pattern of changes over time in myocardial blood flow and microvascular dilator capacity in patients with normally functioning cardiac allografts. Am J Cardiol (1998) 0.78

Comparison of two aspirin doses on ischemic stroke in post-myocardial infarction patients in the warfarin (Coumadin) Aspirin Reinfarction Study (CARS). Am J Cardiol (2001) 0.78

Long-term clinical outcome of patients with prior myocardial infarction after palliative radiofrequency catheter ablation for frequent ventricular tachycardia. Am J Cardiol (2001) 0.77

The effect of potassium ion depletion on postinfarction canine cardiac arrhythmias. Circulation (1988) 0.77

Impact of surgical relief of outflow obstruction on thallium perfusion abnormalities in hypertrophic cardiomyopathy. Circulation (1992) 0.77

Malfunction of implantable cardioverter defibrillators placed by a nonthoracotomy approach: frequency of malfunction and value of chest radiography in determining cause. AJR Am J Roentgenol (1995) 0.77

Gender differences in presentation, management, and cardiac event-free survival in patients with syncope. Am J Cardiol (1997) 0.77

Torsade de pointes caused by high-dose intravenous haloperidol in cardiac patients. Clin Cardiol (1995) 0.76

Abnormal global left ventricular relaxation occurs early during the development of pharmacologically induced ischemia. J Am Soc Echocardiogr (1999) 0.76

Long-term outcome of enoximone therapy in patients with refractory heart failure. Am Heart J (1993) 0.75

ABC of blood pressure reduction. Br Med J (Clin Res Ed) (1981) 0.75

Assessment of oxygen uptake during the six-minute walk test. The author responds. Chest (1997) 0.75

Efficacy of a tiered therapy defibrillator system used to treat recurrent ventricular arrhythmias refractory to drugs. Br Heart J (1993) 0.75

Adenosine or verapamil for the acute treatment of supraventricular tachycardia? Ann Intern Med (1991) 0.75

Successful implantation of cardioverter-defibrillator systems in patients with elevated defibrillation thresholds. J Am Coll Cardiol (1993) 0.75

Sex and left ventricular volume predict survival in heart transplant candidates with peak oxygen uptake between ten and fourteen milliliters per kilogram per minute. J Heart Lung Transplant (1997) 0.75

Cardiac transplantation: current indications and limitations. Transplant Proc (1991) 0.75

Electrocardiographic pseudo-infarct patterns after implantation of cardioverter-defibrillators. Am Heart J (1995) 0.75

Clinical correlates of the myocardial force-frequency relationship in patients with end-stage heart failure. J Heart Lung Transplant (1997) 0.75

Left ventricular diastolic function in patients with left ventricular systolic dysfunction due to coronary artery disease and effect of nicardipine. Am J Cardiol (1991) 0.75

Drug therapy for atrial fibrillation--interactions with interventional therapy and implications for local drug delivery. Semin Interv Cardiol (1997) 0.75

Diseases of the aorta. Adv Intern Med (1999) 0.75

Actinomycin D is an effective adjunctive immunosuppressive agent in recurrent cardiac allograft rejection. J Heart Lung Transplant (1996) 0.75

Runaway pacemaker in an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol (1998) 0.75

The role of angioplasty in acute myocardial infarction. J Intensive Care Med (1995) 0.75

Left ventricular end-diastolic volume index, age, and maximum heart rate at peak exercise predict survival in patients referred for heart transplantation. J Heart Lung Transplant (1998) 0.75

Lack of compensatory enlargement at sites of coronary vasospasm: identification by ultrasound and successful treatment with stenting. Clin Cardiol (2000) 0.75

Evolving role of sotalol in the management of ventricular tachyarrhythmias. Am J Cardiol (1996) 0.75

Techniques for assessing inotropic effects of drugs in patients with heart failure: application to the evaluation of nicardipine. Am Heart J (1990) 0.75

Comparison of cycle lengths between induced and spontaneous sustained ventricular tachycardia during concordant antiarrhythmic therapy associated with healed myocardial infarction. Am J Cardiol (1996) 0.75

Lymphoma mimics cytomegalovirus-induced hepatitis in a heart transplant recipient. J Heart Lung Transplant (1992) 0.75

Images in cardiovascular medicine. Coronary artery bypass graft surgery of 77-year-old woman. Circulation (1998) 0.75